A prospective, observational study to evaluate the efficacy,safety of AKBBA capsules & topical cream for the management of plaque type psoriasis.

Sami Labs Limited0 个研究点目标入组 24 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 Patients with Mild to Moderate plaque type psoriasis excluding co-morbid conditions.
•2 Chronic plaque type psoriasis or stable psoriasis.
•3 Willing to sign on Informed consent form.

•1 Patients who have more than 50 percent of body surface area covered by psoriasis lesions.
•2 Patients on anticoagulant therapy.
•3 Use of immunosuppressive medication within past 2 months.
•4 Presence of other skin lesions (actinic ketoses or lentigo) or photo damaged skin
•5 Use of systemic or intra lesional therapy or photo (chemo) therapy for psoriasis in the previous two months.
•6 Concomitant bacterial, fungal, or viral skin infections.
•7 Pregnant or sexually active women who do not use contraception.
•8 Non-adherence to the treatment.
•9 Have history of renal, hepatobiliary, or malignant disease, hypertension or recurrent acute infection
•10 History of any other evidence of severe illness or any other conditions that would make the patient, in the opinion of the investigator, unsuitable for the study.

发起方

Sami Labs Limited